v3.26.1
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

A summary of iMDx’s 2010 Plan and 2018 Incentive Plan activity and related information follows:

 

 

Options

 

 

Nonvested RSUs

 

 

Number
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life

 

Aggregate
Intrinsic
Value

 

 

Number
Outstanding

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

(In thousands, except weighted average amounts)

 

Balance at December 31, 2025

 

 

2,251

 

 

$

7.11

 

 

8.92 years

 

$

8,537

 

 

 

852

 

 

$

3.03

 

Awards granted

 

 

69

 

 

$

6.20

 

 

 

 

 

 

 

 

89

 

 

$

5.47

 

Options exercised

 

 

(4

)

 

$

2.86

 

 

 

 

$

11

 

 

n/a

 

 

n/a

 

RSUs vested

 

n/a

 

 

n/a

 

 

 

 

 

 

 

 

(180

)

 

$

3.15

 

Options forfeited/expired

 

 

(2

)

 

$

57.28

 

 

 

 

 

 

 

n/a

 

 

n/a

 

RSUs forfeited

 

n/a

 

 

n/a

 

 

 

 

 

 

 

 

—

 

 

$

—

 

Balance at June 30, 2026

 

 

2,314

 

 

$

7.03

 

 

8.47 years

 

$

5,363

 

 

 

761

 

 

$

3.30

 

Options vested and expected to vest at June 30, 2026

 

 

2,314

 

 

$

7.03

 

 

8.47 years

 

$

5,363

 

 

 

 

 

 

 

Options exercisable at June 30, 2026

 

 

669

 

 

$

15.93

 

 

7.01 years

 

$

1,208

 

 

 

 

 

 

 

Stock-based compensation expense for the period

 

$

751

 

 

 

 

 

 

 

 

 

 

$

525

 

 

 

 

Unrecognized stock-based compensation expense

 

$

3,422

 

 

 

 

 

 

 

 

 

 

$

1,891

 

 

 

 

Weighted average remaining recognition period

 

2.18 years

 

 

 

 

 

 

 

 

 

 

2.17 years

 

 

 

 
Schedule of Assumptions Used to Calculate Fair Value of Stock Options The assumptions used to calculate the Black-Scholes grant date fair value for such time-based awards were as follows:

 

 

Six Months Ended
June 30,

 

 

2026

 

 

2025

 

Expected life

 

5.86 years

 

 

6.18 years

 

Risk-free interest rates

 

 

4.37

%

 

 

4.15

%

Volatility

 

 

90.48

%

 

 

103.71

%

Dividend yield

 

 

0

%

 

 

0

%
Summary of Stock-based Compensation Expense

iMDx recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

(In thousands)

 

Cost of revenues

 

$

—

 

 

$

—

 

 

$

—

 

 

$

—

 

Research and development

 

 

179

 

 

 

173

 

 

 

338

 

 

 

368

 

Sales and marketing

 

 

61

 

 

 

42

 

 

 

119

 

 

 

80

 

General and administrative

 

 

421

 

 

 

289

 

 

 

819

 

 

 

529

 

Total

 

$

661

 

 

$

504

 

 

$

1,276

 

 

$

977